Why Invest In The Nephrology Market?

PGP Partner Ezra Simons recently spoke with Levin Associates to discuss why private equity investment is interested in Nephrology. “Globally we see private equity groups trying to advance the ball around value based care and risk based care models – there is no question that healthcare is heading away from quantity of service and into quality and value. Private equity groups are trying to figure out how to play that. Kidney failure, nephrology’s core disease state, impacts more Americans than just about any other medical specialty.”

Read the full article